Skip to main content
Top
Published in: BMC Medical Research Methodology 1/2021

Open Access 01-12-2021 | Research

Translation, transcultural adaptation and validation to Brazilian Portuguese of tools for adverse drug reaction assessment in children

Authors: Elisangela da Costa Lima, Thais de Barros Fernandes, Adair Freitas, Juliana Freire de Lima Sias, Marcelo Gerardin Poirot Land, Mariana Tschoepke Aires, Louise Bracken, Matthew Peak

Published in: BMC Medical Research Methodology | Issue 1/2021

Login to get access

Abstract

Background

Children are more vulnerable to adverse drug reactions (ADRs) due to complex changes in the body during the growth process and lack specific pharmacoepidemiologic studies. Causality and Avoidability assessment of ADRs are relevant to clinical guidelines development and pharmacovigilance. This study aimed to translate and transcultural adapt two new tools—Liverpool Causality Assessment Tool (LCAT) and the Liverpool Avoidability Assessment Tool (LAAT)—to Brazilian-Portuguese and evaluate the psychometric properties of these tools to analyse ADRs in Brazilian children.

Methods

The validation of the cross-cultural adaptation of tools was obtained by the functional (conceptual, semantic, operational, and measurement) equivalence between the original and translated versions of each instrument. The translated version of LCAT and LAAT was applied to assessing the twenty-six case reports of suspected adverse drug reactions in a Brazilian teaching paediatric hospital. The inter-rater reliability (a pharmacist and a physician) was evaluated using Cronbach’s alpha. The exact agreement percentages (%EA) and extreme disagreement (%ED) were computed. Overall Kappa index was calculated with a 95% confidence interval.

Results

There was a need to modify some terms translated into Portuguese for semantic and conceptual equivalence. The Cronbach’s alpha coefficient values obtained were 0.95 and 0.85, and the weighted Kappa (95% confidence interval) were 0.82 (0.67–0.97) and 0.68 (0.45–0.91) for LCAT and LAAT, respectively. The Brazilian-Portuguese versions of the LCAT and LAAT showed reliable and valid tools for the diagnosis and follow-up of ADRs in children.

Conclusion

The methodological approach allowed the translation, transcultural adaptation, and validation to Brazilian-Portuguese of two easy and quick to perform tools for causality and avoidability of ADRs in children by a multidisciplinary expert specialist committee, including the authors of original tools. We believe these versions may be applied by professionals (patient safety teams) and researchers in Brazil in groups or by a single reviewer.

Trial registration

This study was evaluated and approved by the Research Ethics Committee (Instituto de Pediatria e Puericultura Martagão Gesteira – Federal University of Rio de Janeiro – Number: 3.264.238.
Appendix
Available only for authorised users
Literature
1.
go back to reference Fang H, Lin X, Zhang J, Hong Z, Sugiyama K, Nozaki T, et al. Multifaceted interventions for improving spontaneous reporting of adverse drug reactions in a general hospital in China. BMC Pharmacol Toxicol. 2017;18(1):49.CrossRef Fang H, Lin X, Zhang J, Hong Z, Sugiyama K, Nozaki T, et al. Multifaceted interventions for improving spontaneous reporting of adverse drug reactions in a general hospital in China. BMC Pharmacol Toxicol. 2017;18(1):49.CrossRef
2.
go back to reference Poudel DR, Acharya P, Ghimire S, Dhital R, Bharati R. Burden of hospitalizations related to adverse drug events in the USA: a retrospective analysis from large inpatient database: adverse drug events related hospitalizations in the US. Pharmacoepidemiol Drug Saf. 2017;26(6):635–41.CrossRef Poudel DR, Acharya P, Ghimire S, Dhital R, Bharati R. Burden of hospitalizations related to adverse drug events in the USA: a retrospective analysis from large inpatient database: adverse drug events related hospitalizations in the US. Pharmacoepidemiol Drug Saf. 2017;26(6):635–41.CrossRef
3.
go back to reference Fernandez E, Perez R, Hernandez A, Tejada P, Arteta M, Ramos J. Factors and mechanisms for pharmacokinetic differences between pediatric population and adults. Pharmaceutics. 2011;3(1):53–72.CrossRef Fernandez E, Perez R, Hernandez A, Tejada P, Arteta M, Ramos J. Factors and mechanisms for pharmacokinetic differences between pediatric population and adults. Pharmaceutics. 2011;3(1):53–72.CrossRef
4.
go back to reference Vieira JMDL, de Matos GC, da Silva FAB, Bracken LE, Peak M, Lima EDC. Serious adverse drug reactions and safety signals in children: a nationwide database study. Front Pharmacol. 2020;11:964.CrossRef Vieira JMDL, de Matos GC, da Silva FAB, Bracken LE, Peak M, Lima EDC. Serious adverse drug reactions and safety signals in children: a nationwide database study. Front Pharmacol. 2020;11:964.CrossRef
5.
go back to reference Smyth RL, Peak M, Turner MA, Nunn AJ, Williamson PR, Young B, et al. ADRIC: Adverse Drug Reactions In Children – a programme of research using mixed methods. Programme Grants Appl Res. 2014;2(3):1–184.CrossRef Smyth RL, Peak M, Turner MA, Nunn AJ, Williamson PR, Young B, et al. ADRIC: Adverse Drug Reactions In Children – a programme of research using mixed methods. Programme Grants Appl Res. 2014;2(3):1–184.CrossRef
6.
go back to reference Smyth RMD, Gargon E, Kirkham J, Cresswell L, Golder S, Smyth R, et al. Adverse drug reactions in children—a systematic review. Ross JS, organizador. PLoS One. 2012;7(3):e24061.CrossRef Smyth RMD, Gargon E, Kirkham J, Cresswell L, Golder S, Smyth R, et al. Adverse drug reactions in children—a systematic review. Ross JS, organizador. PLoS One. 2012;7(3):e24061.CrossRef
7.
go back to reference Ithnin M, Mohd Rani MD, Abd Latif Z, Kani P, Syaiful A, Nor Aripin KN, et al. Mobile app design, development, and publication for adverse drug reaction assessments of causality, severity, and preventability. JMIR MHealth UHealth. 2017;5(5):e78.CrossRef Ithnin M, Mohd Rani MD, Abd Latif Z, Kani P, Syaiful A, Nor Aripin KN, et al. Mobile app design, development, and publication for adverse drug reaction assessments of causality, severity, and preventability. JMIR MHealth UHealth. 2017;5(5):e78.CrossRef
8.
go back to reference Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239–45.CrossRef Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239–45.CrossRef
9.
go back to reference Macedo AF, Marques FB, Ribeiro CF, Teixeira F. Causality assessment of adverse drug reactions: comparison of the results obtained from published decisional algorithms and from the evaluations of an expert panel. Pharmacoepidemiol Drug Saf. 2005;14(12):885–90.CrossRef Macedo AF, Marques FB, Ribeiro CF, Teixeira F. Causality assessment of adverse drug reactions: comparison of the results obtained from published decisional algorithms and from the evaluations of an expert panel. Pharmacoepidemiol Drug Saf. 2005;14(12):885–90.CrossRef
10.
go back to reference Agbabiaka TB, Savović J, Ernst E. Methods for causality assessment of adverse drug reactions: a systematic review. Drug Saf. 2008;31(1):21–37.CrossRef Agbabiaka TB, Savović J, Ernst E. Methods for causality assessment of adverse drug reactions: a systematic review. Drug Saf. 2008;31(1):21–37.CrossRef
11.
go back to reference Gallagher RM, Kirkham JJ, Mason JR, Bird KA, Williamson PR, Nunn AJ, et al. Development and inter-rater reliability of the Liverpool adverse drug reaction causality assessment tool. Timmer A, organizador. PLoS One. 2011;6(12):e28096.CrossRef Gallagher RM, Kirkham JJ, Mason JR, Bird KA, Williamson PR, Nunn AJ, et al. Development and inter-rater reliability of the Liverpool adverse drug reaction causality assessment tool. Timmer A, organizador. PLoS One. 2011;6(12):e28096.CrossRef
12.
go back to reference Hallas J, Harvald B, Gram LF, Grodum E, Brøsen K, Haghfelt T, et al. Drug related hospital admissions: the role of definitions and intensity of data collection, and the possibility of prevention. J Intern Med. 1990;228(2):83–90.CrossRef Hallas J, Harvald B, Gram LF, Grodum E, Brøsen K, Haghfelt T, et al. Drug related hospital admissions: the role of definitions and intensity of data collection, and the possibility of prevention. J Intern Med. 1990;228(2):83–90.CrossRef
13.
go back to reference Thiesen S, Conroy EJ, Bellis JR, Bracken LE, Mannix HL, Bird KA, et al. Incidence, characteristics and risk factors of adverse drug reactions in hospitalized children – a prospective observational cohort study of 6,601 admissions. BMC Med. 2013;11(1):237.CrossRef Thiesen S, Conroy EJ, Bellis JR, Bracken LE, Mannix HL, Bird KA, et al. Incidence, characteristics and risk factors of adverse drug reactions in hospitalized children – a prospective observational cohort study of 6,601 admissions. BMC Med. 2013;11(1):237.CrossRef
14.
go back to reference Bracken LE, Nunn AJ, Kirkham JJ, Peak M, Arnott J, Smyth RL, et al. Development of the Liverpool adverse drug reaction avoidability assessment tool. Li Z, organizador. PLoS One. 2017;12(1):e0169393.CrossRef Bracken LE, Nunn AJ, Kirkham JJ, Peak M, Arnott J, Smyth RL, et al. Development of the Liverpool adverse drug reaction avoidability assessment tool. Li Z, organizador. PLoS One. 2017;12(1):e0169393.CrossRef
15.
go back to reference Pernambuco L, Espelt A, Magalhães Junior HV, Lima KC de. Recomendações para elaboração, tradução, adaptação transcultural e processo de validação de testes em Fonoaudiologia. CoDAS. 2017;29(3). Pernambuco L, Espelt A, Magalhães Junior HV, Lima KC de. Recomendações para elaboração, tradução, adaptação transcultural e processo de validação de testes em Fonoaudiologia. CoDAS. 2017;29(3).
16.
go back to reference Reichenheim ME, Moraes CL. Operacionalização de adaptação transcultural de instrumentos de aferição usados em epidemiologia. Rev Saúde Pública. 2007;41(4):665–73.CrossRef Reichenheim ME, Moraes CL. Operacionalização de adaptação transcultural de instrumentos de aferição usados em epidemiologia. Rev Saúde Pública. 2007;41(4):665–73.CrossRef
17.
go back to reference Reichenheim ME, Hökerberg YHM, Moraes CL. Assessing construct structural validity of epidemiological measurement tools: a seven-step roadmap. Cad Saúde Pública. 2014;30(5):927–39.CrossRef Reichenheim ME, Hökerberg YHM, Moraes CL. Assessing construct structural validity of epidemiological measurement tools: a seven-step roadmap. Cad Saúde Pública. 2014;30(5):927–39.CrossRef
18.
go back to reference Lima EDC, de Matos GC, Vieira JMDL, Gonçalves ICDCR, Cabral LM, Turner MA. Suspected adverse drug reactions reported for Brazilian children: cross-sectional study. J Pediatr (Rio J). 2019;95(6):682–8.CrossRef Lima EDC, de Matos GC, Vieira JMDL, Gonçalves ICDCR, Cabral LM, Turner MA. Suspected adverse drug reactions reported for Brazilian children: cross-sectional study. J Pediatr (Rio J). 2019;95(6):682–8.CrossRef
19.
go back to reference Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas. 1960;20(1):37–46.CrossRef Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas. 1960;20(1):37–46.CrossRef
20.
go back to reference Cohen J. Weighted kappa: nominal scale agreement provision for scaled disagreement or partial credit. Psychol Bull. 1968;70(4):213–20.CrossRef Cohen J. Weighted kappa: nominal scale agreement provision for scaled disagreement or partial credit. Psychol Bull. 1968;70(4):213–20.CrossRef
21.
go back to reference Altman DG. Practical statistics for medical research. Boca Raton: Chapman & Hall/CRC; 1999. p. 611. Altman DG. Practical statistics for medical research. Boca Raton: Chapman & Hall/CRC; 1999. p. 611.
22.
go back to reference Tavakol M, Dennick R. Making sense of Cronbach’s alpha. Int J Med Educ. 2011;2:53–5.CrossRef Tavakol M, Dennick R. Making sense of Cronbach’s alpha. Int J Med Educ. 2011;2:53–5.CrossRef
23.
go back to reference de Souza AC, Alexandre NMC, Guirardello EDB. Propriedades psicométricas na avaliação de instrumentos: avaliação da confiabilidade e da validade. Epidemiol E Serviços Saúde. 2017;26(3):649–59.CrossRef de Souza AC, Alexandre NMC, Guirardello EDB. Propriedades psicométricas na avaliação de instrumentos: avaliação da confiabilidade e da validade. Epidemiol E Serviços Saúde. 2017;26(3):649–59.CrossRef
26.
go back to reference Ferner RE, Aronson JK. Preventability of drug-related harms – part i: a systematic review. Drug Saf. 2010;33(11):985–94.CrossRef Ferner RE, Aronson JK. Preventability of drug-related harms – part i: a systematic review. Drug Saf. 2010;33(11):985–94.CrossRef
27.
go back to reference Galindo SR, da Nóbrega Marinho MH, Gatchel RJ, de Paula Santana da Silva T, Viana EHS, Vasconcelos SC, et al. Cross-cultural adaptation of the Pain Medication Questionnaire for use in Brazil. BMC Med Res Methodol. 2019;19(1):188.CrossRef Galindo SR, da Nóbrega Marinho MH, Gatchel RJ, de Paula Santana da Silva T, Viana EHS, Vasconcelos SC, et al. Cross-cultural adaptation of the Pain Medication Questionnaire for use in Brazil. BMC Med Res Methodol. 2019;19(1):188.CrossRef
Metadata
Title
Translation, transcultural adaptation and validation to Brazilian Portuguese of tools for adverse drug reaction assessment in children
Authors
Elisangela da Costa Lima
Thais de Barros Fernandes
Adair Freitas
Juliana Freire de Lima Sias
Marcelo Gerardin Poirot Land
Mariana Tschoepke Aires
Louise Bracken
Matthew Peak
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Medical Research Methodology / Issue 1/2021
Electronic ISSN: 1471-2288
DOI
https://doi.org/10.1186/s12874-021-01315-9

Other articles of this Issue 1/2021

BMC Medical Research Methodology 1/2021 Go to the issue